课题基金 / 基金详情

项目摘要

项目成果

ERIC MICHAEL REIMAN的其他基金

相似基金

相关文献

中文摘要
翻译
神经病理学核心是阿尔茨海默病核心中心(ADCC)的重要组成部分。在一生中,阿尔茨海默病(AD)的体征和症状与其他几种疾病没有足够的区别,导致大约25%的受试者被误诊,即使在最先进的中心。因此,由有执照的神经病理学家对死后的大脑进行检查是唯一的方法
英文摘要
The Neuropathology Core is an essential part of the Alzheimer's Disease Core Center (ADCC). During life, the signs and symptoms of Alzheimer's disease (AD) are not sufficiently different from several other conditions, resulting in misdiagnosis, even at the most advanced centers, in about 25% of subjects. Examination of the brain after death by a certified Neuropathologist is therefore the only means by which a definite diagnosis can be attained, allowing all research results to be correctly interpreted. A second major role of the Neuropathology Core is to provide neuropathologically characterized brain tissue to basic scientists, both within the ADCC and outside it, enabling them to discover the underlying molecular mechanisms of disease and design appropriate therapeutic interventions. A detailed understanding of the genetic and molecular processes of disease pathogenesis, obtained by comparative study of diseased and non-diseased brain tissue, remains the major approach to finding such interventions. A third important goal of the Neuropathology Core is to help develop a collaborative synergy that will enhance the research productivity of the entire Center. Our Specific Aims are as follows: 1)To provide precise neuropathoiogic diagnoses of patients that have been clinically studied by the Cinical Core. 2) To provide basic scientists with neuropathologically characterized brain tissue suitable for the elucidation of the molecular mechanisms of AD and related disorders, and especially to assist researchers in their studies of the earliest stages of Alzheimer's disease, with the goal of identifying therapeutic strategies that will prevent the disease or slow its progress. 3) To share neuropathological skills, expertise, knowledge and data with all ADCC investigators and the scientific community at large, facilitating a collaborative synergy that will enhance the research productivity of all.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Arizona Alzheimer's Disease Research Center
Arizona Alzheimer's Disease Research Center
Core A: Administrative Core
Alzheimer's Prevention Initiative APOE4 Trial
  • 批准号:
    8605297
  • 项目类别:
  • 资助金额:
    $3326.02万
  • 财政年份:
    2013
  • 负责人:
    ERIC MICHAEL REIMAN
  • 依托单位:
海外基金